Targeted mutant interferon-beta and uses thereof
US11236141B2 · kind B2 · utility
3Cited by
4References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 12, 2017 |
| Grant date | Feb 1, 2022 |
| Priority date | — |
| Expiry date | Jan 6, 2038 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates, in part, to chimeric proteins comprising mutant interferon-β and their use as therapeutic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.